Skip to main navigation Skip to search Skip to main content

A Phase 3, Multicenter, Open-Label Safety Study to Evaluate the Long-Term Safety and Tolerability of SAGE-718

Project: Research

Project Details

StatusFinished
Effective start/end date01/3/23 → 05/31/26

Funding

  • Sage Therapeutics Incorporated: $73,718.54